Carbamazepine Clearance in Paediatric Epilepsy Patients
- 1 September 1989
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 17 (3) , 208-216
- https://doi.org/10.2165/00003088-198917030-00006
Abstract
Carbamazepine clearance was studied in Black paediatric epilepsy patients, 90 receiving monotherapy and 17 on combination therapy. For patients on monotherapy the following relationships are shown: clearance decreases with increasing body mass (r = 0.87); clearance increases with increasing dose (r = 0.70); and mean clearances for males are higher than those for females throughout the mass ranges, though the difference is not statistically significant. In the case of patients on carbamazepine plus another anticonvulsant, clearance also decreases with increasing body mass, and increases with increasing dose. Furthermore, in the mass groups which corresponded with those on monotherapy, mean carbamazepine clearance is higher by a factor varying from 1.3 to 1.7; in the corresponding dosage groups, it is higher by a factor of between 1.4 and 1.7.This publication has 29 references indexed in Scilit:
- Carbamazepine Efficacy and Utilization in ChildrenEpilepsia, 1987
- Serum Concentrations of Carbamazepine and Its Epoxide and Diol Metabolites in Epileptic PatientsTherapeutic Drug Monitoring, 1987
- POPULATION PHARMACOKINETICS OF PHENYTOIN IN SOUTH-AFRICAN BLACK PATIENTS1987
- Carbamazepine Metabolism in ManClinical Pharmacokinetics, 1985
- Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data???Clinical Pharmacokinetics, 1983
- Single Drug or Combination Therapy for Epilepsy?Drugs, 1981
- Autoinduction of carbamazepine metabolism in children examined by a stable isotope techniqueClinical Pharmacology & Therapeutics, 1980
- Effect of Dose Increments on Serum Carbamazepine Concentration in Epileptic PatientsClinical Pharmacokinetics, 1980
- Carbamazepine: absorption, distribution, and excretion.1975
- Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple dosesEuropean Journal of Clinical Pharmacology, 1975